Listen on the go
CORRECT!
Next question
touchONCOLOGY touchONCOLOGY
    • FILTER YOUR SEARCH
    Content Type:
    Speciality:
    More Specialities
    Conference:
    More Conferences

    • Paediatric Oncology

    EU PEDIATRIC ONCOLOGY PARTNER

    An Introduction to Paediatric Oncology

    Paediatric cancers are treated by a multidisciplinary team that includes paediatric oncologists, radiation oncologists, paediatric surgeons and specialist nurses. Significant treatment advances have been made over the past decade, including the introduction of targeted therapies such as TKIs and immunotherapies, which have dramatically improved patient outcomes across numerous cancer types.

    Expert video highlights and insights from the conference hub and comprehensive peer-reviewed articles from our journal portfolio provide updates on the ever-changing landscape.

    Our supporting partners do not constitute an endorsement of the content on this page.

    Paediatric Oncology Content

    Breast Cancer, Dermatological Cancers, Gastrointestinal Cancers, Genitourinary Cancer, Gynaecological Cancers, Haematological Malignancies, Haematology, Head and Neck Cancer, Immunotherapy, Lung Cancer, Endocrine Cancers, Paediatric Oncology
    Space medicine: Can microgravity transform pharmaceutical manufacturing?

    In our latest episode, we delve into the world of space medicine to explore how drug crystallization in microgravity could revolutionize biologic drug administration. Joining us is Dr Katie King, CEO of BioOrbit, to discuss the science, challenges, and technological advancements that could make space-based drug production a reality.

    touchEXPERT BRIEFING
    Front-line consolidation therapy in B-ALL: current challenges and novel strategies
    For HCPs in: Global (excluding the UK and USA)
    View Time: 28 mins Sponsored content

    Watch adult and paediatric oncologists discuss unmet needs in front-line B-ALL consolidation and in-development novel strategies.

     

    Date of Preparation: December 2023
    Paediatric Oncology, Neuro-oncology
    Developed by Touch
    Pamela Kearns: Exciting steps forward through collaborative clinical trials in paediatric oncology
    Watch Time: 4 mins

    Professor Pamela Kearns (Director, Cancer Research UK Clinical Trials Unit, UK) discusses some of the most important clinical trials she is currently involved with in the field of paediatric oncology. She includes: The Glo-BNHL trial, which is the largest platform trial in paediatric and adolescent relapsed and refractory B-cell malignancies globally (0:32) INTER-EWING, a clinical […]

    Paediatric Oncology
    Developed by Touch
    Pamela Kearns: Highlights from SIOP Europe 2023
    Watch Time: 3 mins

    Professor Pamela Kearns (University of Birmingham, UK) joins touchONCOLOGY to discuss her highlights from the first face-to-face annual meeting of the European Society of Paediatric Oncology (SIOPE Europe) since the COVID-19 pandemic (Valencia, 8-12 May 2023). She celebrates joint sessions with patient advocacy groups, and the importance of patient and parent experience in the debate […]

    Paediatric Oncology
    Developed by Touch
    Carmelo Rizzari: Highlights from the SIOPE Europe 2023 Annual Meeting!
    Watch Time: 5 mins

    President of the European Society for Paediatric Oncology (SIOPE Europe), Prof Carmelo Rizzari, discusses his highlights from the SIOPE Europe 2023 annual meeting. This year it was attended by 1200 individuals, bringing together healthcare professionals, parents, patients, caregivers, young oncologists, nurses and many other groups involved in the paediatric oncology.  There were 150 sessions and […]

    Paediatric Oncology
    Developed by Touch
    Carmelo Rizzari: An overview of SIOP Europe
    Watch Time: 25 mins

    President of the European Society for Paediatric Oncology (SIOPE Europe), Prof Carmelo Rizzari, provides an interesting update on the society, the recent annual meeting, the mission and future objectives. Topics covered  SIOPE structure (01:11) Membership, Board and SIOPE Office (05:00) Initiatives and Mission (08:00) Education, AI, GDPR (09:30)  Support for survivors (12:10) SIOPE Meeting 2023 […]

    Paediatric Oncology, Neuro-oncology
    Pan-RAF Inhibitors for Paediatric Low-grade Gliomas Offer New Opportunities in Targeted Therapy
    David S Ziegler

    touchREVIEWS in Oncology & Haematology. 2023;19(1):4-5 DOI: https://doi.org/10.17925/OHR.2023.19.1.4

    Paediatric low-grade gliomas (pLGGs) most commonly develop in the cerebellum and can be resected safely, with minimal neurological complications and long-term cure achieved following surgery alone.1 However, a large proportion of pLGGs that develop in other parts of the brain remain unresectable and ultimately manifest as a chronic disease.2 The most common location at which unresectable pLGG […]

    Paediatric Oncology
    Pamela Kearns: SIOP Europe: The Importance of Collaboration to Make Change
    Watch Time: 7 mins

    touchONCOLOGY spoke to Professor Pamela Kearns (University of Birmingham, UK) to discuss the importance of SIOP Europe, and the power of bringing together experts, patients and parents from the continent as one voice with one objective. Questions Why is it important to have organizations like SIOP Europe? (00:21-02:09) Is there any message you would like […]

    COVID-19, Paediatric Oncology
    Developed by Touch
    Pamela Kearns: Leading SIOP Europe during the COVID-19 Pandemic
    Watch Time: 3 mins

    touchONCOLOGY spoke to Professor Pamela Kearns (University of Birmingham, UK) to discuss her experience as President of SIOP Europe during the COVID-19 pandemic, and the biggest achievements of the European paediatric oncology community during that time. Questions How would you describe your experience as the SIOP Europe President (2019–21) and how the COVID-19 pandemic influenced […]

    In Partnership with...
    Useful Links:
    About us Society Partners Press Releases Contact Us Permissions Terms & Conditions Privacy Policy Cookie Preferences
    Connect With Us:

    Other websites from Touch Medical Media:

    touchONCOLOGY
    touchOPHTHALMOLOGY
    touchENDOCRINOLOGY
    touchNEUROLOGY
    touchCARDIO
    touchRESPIRATORY
    touchIMMUNOLOGY
    touchINFECTIOUS DISEASES
    touchHAEMATOLOGY
    touchDERMATOLOGY

    Copyright® 2024 Touch Medical Media. Touch Medical Media Group Holdings Limited, a private limited company registered in England and Wales at 3 Stockport Exchange | Stockport | Cheshire | SK1 3GG | UK with registered number 08197142.

    touchONCOLOGY is for informational purposes and intended for healthcare professionals only. Its content should not be considered medical advice, diagnosis or treatment recommendations.

    Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
    Close Popup